Activation of hepatocyte growth factor by urokinase-type plasminogen activator is ionic strength-dependent

被引:11
|
作者
Mars, WM
Jo, M
Gonias, SL
机构
[1] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA
[2] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA
关键词
epsilon-amino-caproic acid (EACA); hepatocyte growth factor (HGF); HGF receptor (MET); ionic strength; urokinase-type plasminogen activator (u-PA); u-PA receptor (u-PAR);
D O I
10.1042/BJ20042028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The hepatocyte growth factor (HGF) is a multifunctional cytokine that is produced as latent scHGF (single chain HGF). Various proteases reportedly cleave scHGF to generate the active two-chain form (HGF), including u-PA (urokinase-type plasminogen activator), t-PA (tissue-type plasminogen activator), kallikrein, Factor XIa, Factor XIIa, HGF activator and matriptase. Considerable evidence indicates that, in vivo, u-PA activates scHGF in the liver; however, the in vivo results have not been uniformly supported by in vitro experiments. We now report that cleavage of scHGF by high-molecular-mass u-PA (abbreviated u-PA throughout) is sensitive to ionic strength. scHGF cleavage by u-PA was accelerated as the ionic strength was decreased. This result was equivalent irrespective of whether the predominant anion was chloride or acetate. Lmw-u-PA (low-molecular-mass u-PA) was ineffective at cleaving scHGF, regardless of ionic strength. Although scHGF shares homology with plasminogen, EACA (epsilon-amino-caproic acid) did not regulate u-PA-mediated scHGF cleavage. Soluble HGF receptor (MET) and soluble u-PAR (u-PA receptor) inhibited the scHGF cleavage. These results support a model in which the ability of u-PA to activate scHGF in vivo may be highly dependent on local conditions within the extracellular space.
引用
收藏
页码:311 / 315
页数:5
相关论文
共 50 条
  • [41] Properties of the urokinase-type plasminogen activator modified with phenylglyoxal
    Moukhametova, LI
    Aisina, RB
    Lomakina, GY
    Varfolomeev, SD
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2002, 28 (04) : 278 - 283
  • [42] THE CHICKEN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR GENE
    LESLIE, ND
    KESSLER, CA
    BELL, SM
    DEGEN, JL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1990, 265 (03) : 1339 - 1344
  • [43] Elucidating novel urokinase-type plasminogen activator inhibitors
    Smith, E.
    Spencer, J.
    Ali, M.
    Abdinejad, M.
    Kankanala, J.
    Fishwick, C.
    Philippou, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (06) : E18 - E18
  • [44] A CELLULAR RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    BELIN, D
    BACCINO, D
    WOHLWEND, A
    ESTREICHER, A
    HUARTE, J
    VASSALLI, JD
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 46 - 46
  • [45] Is the urokinase-type plasminogen activator system a reliable prognostic factor in gastric cancer?
    Luebke, T.
    Baldus, S. E.
    Spieker, D.
    Grass, G.
    Bolischweiler, E.
    Schneider, P. M.
    Thiele, J.
    Dienes, H. P.
    Hoelscher, A. H.
    Monig, S. P.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2006, 21 (03): : 162 - 169
  • [46] Elucidating novel urokinase-type plasminogen activator inhibitors
    Smith, E. L.
    John, S.
    Abdinejad, M.
    Kankanala, J.
    Fishwick, C. W. G.
    Philippou, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 819 - 819
  • [47] Urokinase-type plasminogen activator in carcinomatous pleural fluid
    Ishikawa, H
    Satoh, H
    Hasegawa, S
    Yazawa, T
    Naito, T
    Yamashita, YT
    Ohtsuka, M
    Ogata, T
    Kamma, H
    EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (07) : 1566 - 1571
  • [48] Urokinase-Type Plasminogen Activator Inhibits Efferocytosis of Neutrophils
    Yang, Yanping
    Friggeri, Arnaud
    Banerjee, Sami
    Bdeir, Khalil
    Cines, Douglas B.
    Liu, Gang
    Abraham, Edward
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 182 (12) : 1516 - 1523
  • [49] Properties of the Urokinase-Type Plasminogen Activator Modified with Phenylglyoxal
    L. I. Moukhametova
    R. B. Aisina
    G. Yu. Lomakina
    S. D. Varfolomeev
    Russian Journal of Bioorganic Chemistry, 2002, 28 : 278 - 283
  • [50] Urokinase-type plasminogen activator in human gliomas in vitro
    Gillespie, J
    McCormick, D
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1996, 22 (05) : 454 - 454